{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:50:25Z","timestamp":1792597825126,"version":"4.5.0"},"reference-count":117,"publisher":"Bentham Science Publishers Ltd.","issue":"24","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2020,11,2]]},"abstract":"<jats:sec><jats:title\/><jats:p>Over the past decades, a tremendous rise in invasive fungal infection diseases attributed to the yeast Candida albicans in immunocompromised individuals poses a seriously challenging issue. Another concern is the emergence of multi-drug resistant pathogens to the existing medicines due to their overuse and misuse. It was recently reported that 25-55% of the mortality rate is caused by invasive infection. Despite a large variety of drugs being available to treat invasive candidiasis, only two of them contain a 1,2,4-triazole core, namely Fluconazole and itraconazole, which are efficient in treating infection induced by fungal Candida species. Moreover, long-term therapy associated with azole medications has led to an increase in azole resistance as well as a high risk of toxicity. Despite numerous outstanding achievements in antifungal drug discovery, development of novel, safer and potent antifungal agents while overcoming the resistance problem associated with the current drugs is becoming the main focus of medicinal chemists. Therefore, this review outlines the breakthroughs in medicinal chemistry research regarding 1,2,4- triazole-based derivatives as potential antifungal agents in the past decade. In addition, the structureactivity relationship of these compounds is also discussed.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026620666200704140107","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T18:06:52Z","timestamp":1593886012000},"page":"2235-2258","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review"],"prefix":"10.2174","volume":"20","author":[{"given":"Christophe","family":"Tratrat","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.4014\/jmb.1807.07002","volume":"28","author":"Lee H.","year":"2018","unstructured":"Lee H.; Lee D.G.; Novel approaches for efficient antifungal drug action. J Microbiol Biotechnol 2018,28(11),1771-1781","journal-title":"J Microbiol Biotechnol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2174\/0929867306666220401183122","volume":"6","author":"Ablordeppey S.Y.","year":"1999","unstructured":"Ablordeppey S.Y.; Fan P.; Ablordeppey J.H.; Mardenborough L.; Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development. Curr Med Chem 1999,6(12),1151-1195","journal-title":"Curr Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4155\/cli.11.137","volume":"1","author":"Girmenia C.","year":"2011","unstructured":"Girmenia C.; Finolezzi E.; New-generation triazole antifungal drugs: Review of the Phase II and III trials. Clin Investig (Lond) 2011,1,1577-1594","journal-title":"Clin Investig (Lond)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1086\/323895","volume":"33","author":"Singh N.","year":"2001","unstructured":"Singh N.; Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 2001,33(10),1692-1696","journal-title":"Clin Infect Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1128\/CMR.9.4.499","volume":"9","author":"Fridkin S.K.","year":"1996","unstructured":"Fridkin S.K.; Jarvis W.R.; Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996,9(4),499-511","journal-title":"Clin Microbiol Rev"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fgb.2019.103254","volume":"132","author":"Hokken M.W.J.","year":"2019","unstructured":"Hokken M.W.J.; Zwaan B.J.; Melchers W.J.G.; Verweij P.E.; Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi. Fungal Genet Biol 2019,132","journal-title":"Fungal Genet Biol"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","volume":"3","author":"Bongomin F.","year":"2017","unstructured":"Bongomin F.; Gago S.; Oladele R.O.; Denning D.W.; Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel) 2017,3(4)","journal-title":"J Fungi (Basel)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ejmech.2019.05.047","volume":"177","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; Tian L.; Sun N.; Sun Y.; Chen Y.; Wang X.; Zhao S.; Su X.; Zhao D.; Cheng M.; Design, synthesis, and structure-activity relationship studies of l-amino alcohol derivatives as broad-spectrum antifungal agents. Eur J Med Chem 2019,177,374-385","journal-title":"Eur J Med Chem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1358\/dot.2015.51.12.2421058","volume":"51","author":"Peyton L.R.","year":"2015","unstructured":"Peyton L.R.; Gallagher S.; Hashemzadeh M.; Triazole antifungals: a review. Drugs Today (Barc) 2015,51(12),705-718","journal-title":"Drugs Today (Barc)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","volume":"8","author":"Scorzoni L.","year":"2017","unstructured":"Scorzoni L.; de Paula E.; Silva, A.C.; Marcos, C.M.; Assato, P.A.; de Melo, W.C.; de Oliveira, H.C.; Costa-Orlandi, C.B.; Mendes-Giannini, M.J.; Fusco-Almeida, A.M. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol 2017,8,36-36","journal-title":"Front Microbiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","volume":"5","author":"Cowen L.E.","year":"2014","unstructured":"Cowen L.E.; Sanglard D.; Howard S.J.; Rogers P.D.; Perlin D.S.; Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med 2014,5(7),a019752-a019752","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=12","first-page":"488","volume":"2","author":"Arikan S.","year":"2001","unstructured":"Arikan S.; Rex J.H.; Nystatin LF (Aronex\/Abbott). Current opinion in investigational drugs (London, England : 2000), 2001,2(4),488-495"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","volume":"362","author":"Denning D.W.","year":"2003","unstructured":"Denning D.W.; Echinocandin antifungal drugs. Lancet 2003,362(9390),1142-1151","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1517\/14656566.2010.493875","volume":"11","author":"Moudgal V.","year":"2010","unstructured":"Moudgal V.; Sobel J.; Antifungals to treat Candida albicans. Expert Opin Pharmacother 2010,11(12),2037-2048","journal-title":"Expert Opin Pharmacother"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","volume":"13","author":"Allen D.","year":"2015","unstructured":"Allen D.; Wilson D.; Drew R.; Perfect J.; Azole antifungals: 35 years of invasive fungal infection management. Expert Rev Anti Infect Ther 2015,13(6),787-798","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1517\/14656566.4.8.1277","volume":"4","author":"Herbrecht R.","year":"2003","unstructured":"Herbrecht R.; Natarajan-Am\u00e9 S.; Nivoix Y.; Letscher-Bru V.; The lipid formulations of amphotericin B. Expert Opin Pharmacother 2003,4(8),1277-1287","journal-title":"Expert Opin Pharmacother"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","volume":"26","author":"Laniado-Labor\u00edn R.","year":"2009","unstructured":"Laniado-Labor\u00edn R.; Cabrales-Vargas M.N.; Amphotericin B: side effects and toxicity. Rev Iberoam Micol 2009,26(4),223-227","journal-title":"Rev Iberoam Micol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","volume":"1770","author":"Lepesheva G.I.","year":"2007","unstructured":"Lepesheva G.I.; Waterman M.R.; Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochim Biophys Acta 2007,1770(3),467-477","journal-title":"Biochim Biophys Acta"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fphar.2019.00080","volume":"10","author":"Di Mambro T.","year":"2019","unstructured":"Di Mambro T.; Guerriero I.; Aurisicchio L.; Magnani M.; Marra E.; The yin and yang of current antifungal therapeutic strategies: how can we harness our natural defenses? Front Pharmacol 2019,10,80-80","journal-title":"Front Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd.2017.46","volume":"16","author":"Perfect J.R.","year":"2017","unstructured":"Perfect J.R.; The antifungal pipeline: a reality check. Nat Rev Drug Discov 2017,16(9),603-616","journal-title":"Nat Rev Drug Discov"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fmicb.2019.00691","volume":"10","author":"Zhang J.","year":"2019","unstructured":"Zhang J.; Li L.; Lv Q.; Yan L.; Wang Y.; Jiang Y.; The fungal CYP51S: their functions, structures, related drug resistance, and inhibitors. Front Microbiol 2019,10,691-691","journal-title":"Front Microbiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1574-6968.1991.tb04517.x","volume":"63","author":"Barrett-Bee K.","year":"1991","unstructured":"Barrett-Bee K.; Newboult L.; Pinder P.; Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum. FEMS Microbiol Lett 1991,63(2-3),127-131","journal-title":"FEMS Microbiol Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7897\/2230-8407.087112","volume":"8","author":"Kaur P.","year":"2017","unstructured":"Kaur P.; Chawla A.; 1,2,4-triazole: A review of pharmacological activities. Intl Res J Pharm 2017,8,10-29","journal-title":"Intl Res J Pharm"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/jac\/44.4.429","volume":"44","author":"Martin M.V.","year":"1999","unstructured":"Martin M.V.; The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review. J Antimicrob Chemother 1999,44(4),429-437","journal-title":"J Antimicrob Chemother"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1517\/14728214.10.1.21","volume":"10","author":"Chen A.","year":"2005","unstructured":"Chen A.; Sobel J.D.; Emerging azole antifungals. Expert Opin Emerg Drugs 2005,10(1),21-33","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","volume":"79","author":"Benitez L.L.","year":"2019","unstructured":"Benitez L.L.; Carver P.L.; Adverse effects associated with long-term administration of azole antifungal agents. Drugs 2019,79(8),833-853","journal-title":"Drugs"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019703","volume":"4","author":"Roemer T.","year":"2014","unstructured":"Roemer T.; Krysan D.J.; Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med 2014,4(5)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3389\/fmicb.2018.02892","volume":"9","author":"Wang T.","year":"2018","unstructured":"Wang T.; Shao J.; Da W.; Li Q.; Shi G.; Wu D.; Wang C.; Strong synergism of palmatine and fluconazole\/itraconazole against planktonic and biofilm cells of candida species and efflux-associated antifungal mechanism. Front Microbiol 2018,9,2892-2892","journal-title":"Front Microbiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/2231-4040.161515","volume":"6","author":"Gupta D.","year":"2015","unstructured":"Gupta D.; Jain D.K.; Synthesis, antifungal and antibacterial activity of novel 1,2,4-triazole derivatives. J Adv Pharm Technol Res 2015,6(3),141-146","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1128\/AAC.00054-16","volume":"60","author":"Andes D.","year":"2016","unstructured":"Andes D.; Azie N.; Yang H.; Harrington R.; Kelley C.; Tan R-D.; Wu E.Q.; Franks B.; Kristy R.; Lee E.; Khandelwal N.; Spalding J.; Drug-drug interaction associated with mold-active triazoles among hospitalized patients. Antimicrob Agents Chemother 2016,60(6),3398-3406","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tox.2006.08.007","volume":"228","author":"Tr\u00f6sken E.R.","year":"2006","unstructured":"Tr\u00f6sken E.R.; Adamska M.; Arand M.; Zarn J.A.; Patten C.; V\u00f6lkel W.; Lutz W.K.; Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. Toxicology 2006,228(1),24-32","journal-title":"Toxicology"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2019.02.008","volume":"37","author":"Cort\u00e9s J.C.G.","year":"2019","unstructured":"Cort\u00e9s J.C.G.; Curto M.\u00c1.; Carvalho V.S.D.; P\u00e9rez P.; Ribas J.C.; The fungal cell wall as a target for the development of new antifungal therapies. Biotechnol Adv 2019,37(6)","journal-title":"Biotechnol Adv"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.2174\/15680266113136660195","volume":"13","author":"Geronikaki A.","year":"2013","unstructured":"Geronikaki A.; Fesatidou M.; Kartsev V.; Macaev F.; Synthesis and biological evaluation of potent antifungal agents. Curr Top Med Chem 2013,13(21),2684-2733","journal-title":"Curr Top Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.biopha.2018.12.009","volume":"110","author":"Nami S.","year":"2019","unstructured":"Nami S.; Aghebati-Maleki A.; Morovati H.; Aghebati-Maleki L.; Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases. Biomed Pharmacother 2019,110,857-868","journal-title":"Biomed Pharmacother"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1128\/AAC.46.2.308-314.2002","volume":"46","author":"Matsumoto M.","year":"2002","unstructured":"Matsumoto M.; Ishida K.; Konagai A.; Maebashi K.; Asaoka T.; Strong antifungal activity of SS750, a new triazole derivative, is based on its selective binding affinity to cytochrome P450 of fungi. Antimicrob Agents Chemother 2002,46(2),308-314","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1128\/AAC.46.11.3644-3647.2002","volume":"46","author":"Cuenca-Estrella M.","year":"2002","unstructured":"Cuenca-Estrella M.; Lee-Yang W.; Ciblak M.A.; Arthington-Skaggs B.A.; Mellado E.; Warnock D.W.; Rodriguez-Tudela J.L.; Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species. Antimicrob Agents Chemother 2002,46(11),3644-3647","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1021\/jm051211n","volume":"49","author":"Sheng C.","year":"2006","unstructured":"Sheng C.; Zhang W.; Ji H.; Zhang M.; Song Y.; Xu H.; Zhu J.; Miao Z.; Jiang Q.; Yao J.; Zhou Y.; Zhu J.; L\u00fc J.; Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking. J Med Chem 2006,49(8),2512-2525","journal-title":"J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.bmcl.2007.03.074","volume":"17","author":"Park J.S.","year":"2007","unstructured":"Park J.S.; Yu K.A.; Kang T.H.; Kim S.; Suh Y.G.; Discovery of novel indazole-linked triazoles as antifungal agents. Bioorg Med Chem Lett 2007,17(12),3486-3490","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1016\/j.bmcl.2008.04.056","volume":"18","author":"Liu P.","year":"2008","unstructured":"Liu P.; Zhu S.; Li P.; Xie W.; Jin Y.; Sun Q.; Wu Q.; Sun P.; Zhang Y.; Yang X.; Jiang Y.; Zhang D.; Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents. Bioorg Med Chem Lett 2008,18(11),3261-3265","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=40","first-page":"1","volume":"22","author":"Pfaller M.","year":"2008","unstructured":"Pfaller M.; Chaturvedi V.; Espinel-Ingroff A.; Ghannoum M.; Gosey L.L.; Odds F.C.; Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard second edition. CLSI document M27-A2 (ISBN 1-56238-469- 4).Clin Lab Stand Inst; , 2008,22,1-51"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1128\/AAC.01092-06","volume":"51","author":"Mellado E.","year":"2007","unstructured":"Mellado E.; Garcia-Effron G.; Alc\u00e1zar-Fuoli L.; Melchers W.J.; Verweij P.E.; Cuenca-Estrella M.; Rodr\u00edguez-Tudela J.L.; A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007,51(6),1897-1904","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22071150","volume":"22","author":"Sadeghpour H.","year":"2017","unstructured":"Sadeghpour H.; Khabnadideh S.; Zomorodian K.; Pakshir K.; Hoseinpour K.; Javid N.; Faghih-Mirzaei E.; Rezaei Z.; Design, synthesis, and biological activity of new triazole and nitro-triazole derivatives as antifungal agents. Molecules 2017,22(7)","journal-title":"Molecules"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.bmcl.2009.01.048","volume":"19","author":"Chai X.","year":"2009","unstructured":"Chai X.; Zhang J.; Yu S.; Hu H.; Zou Y.; Zhao Q.; Dan Z.; Zhang D.; Wu Q.; Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols. Bioorg Med Chem Lett 2009,19(6),1811-1814","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.bmcl.2008.02.027","volume":"18","author":"Giraud F.","year":"2008","unstructured":"Giraud F.; Log\u00e9 C.; Pagniez F.; Crepin D.; Le Pape P.; Le Borgne M.; Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents. Bioorg Med Chem Lett 2008,18(6),1820-1824","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bmcl.2008.11.101","volume":"19","author":"Giraud F.","year":"2009","unstructured":"Giraud F.; Guillon R.; Log\u00e9 C.; Pagniez F.; Picot C.; Le Borgne M.; Le Pape P.; Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents. Bioorg Med Chem Lett 2009,19(2),301-304","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1016\/j.tetlet.2006.03.199","volume":"47","author":"Lebouvier N.","year":"2006","unstructured":"Lebouvier N.; Giraud F.; Corbin T.; Na Y.M.; Le Baut G.; Marchand P.; Le Borgne M.; Efficient microwave-assisted synthesis of 1-(1H-indol-1-yl)-2-phenyl-3-(1H-1, 2, 4-triazol-1-yl) propan-2-ols as antifungal agents. Tetrahedron Lett 2006,47(36),6479-6483","journal-title":"Tetrahedron Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ejmech.2008.11.007","volume":"44","author":"Chai X.","year":"2009","unstructured":"Chai X.; Zhang J.; Hu H.; Yu S.; Sun Q.; Dan Z.; Jiang Y.; Wu Q.; Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase. Eur J Med Chem 2009,44(5),1913-1920","journal-title":"Eur J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1517\/13543784.15.6.579","volume":"15","author":"Aperis G.","year":"2006","unstructured":"Aperis G.; Mylonakis E.; Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations. Expert Opin Investig Drugs 2006,15(6),579-602","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1747-0285.2010.01038.x","volume":"76","author":"Guan Z.","year":"2010","unstructured":"Guan Z.; Chai X.; Yu S.; Hu H.; Jiang Y.; Meng Q.; Wu Q.; Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents. Chem Biol Drug Des 2010,76(6),496-504","journal-title":"Chem Biol Drug Des"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1016\/j.bmcl.2009.08.089","volume":"19","author":"Guillon R.","year":"2009","unstructured":"Guillon R.; Giraud F.; Log\u00e9 C.; Le Borgne M.; Picot C.; Pagniez F.; Le Pape P.; Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols. Bioorg Med Chem Lett 2009,19(20),5833-5836","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/DDDT.S58680","volume":"8","author":"Yu S.","year":"2014","unstructured":"Yu S.; Chai X.; Wang Y.; Cao Y.; Zhang J.; Wu Q.; Zhang D.; Jiang Y.; Yan T.; Sun Q.; Triazole derivatives with improved in vitro antifungal activity over azole drugs. Drug Des Devel Ther 2014,8,383-390","journal-title":"Drug Des Devel Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1128\/AAC.01630-08","volume":"53","author":"Sheng C.","year":"2009","unstructured":"Sheng C.; Miao Z.; Ji H.; Yao J.; Wang W.; Che X.; Dong G.; L\u00fc J.; Guo W.; Zhang W.; Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding. Antimicrob Agents Chemother 2009,53(8),3487-3495","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1248\/bpb.30.1246","volume":"30","author":"Chen S.H.","year":"2007","unstructured":"Chen S.H.; Sheng C.Q.; Xu X.H.; Jiang Y.Y.; Zhang W.N.; He C.; Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues. Biol Pharm Bull 2007,30(7),1246-1253","journal-title":"Biol Pharm Bull"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1021\/jm020362c","volume":"46","author":"Ji H.","year":"2003","unstructured":"Ji H.; Zhang W.; Zhang M.; Kudo M.; Aoyama Y.; Yoshida Y.; Sheng C.; Song Y.; Yang S.; Zhou Y.; L\u00fc J.; Zhu J.; Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi. J Med Chem 2003,46(4),474-485","journal-title":"J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1016\/j.ejmech.2009.05.018","volume":"44","author":"Che X.","year":"2009","unstructured":"Che X.; Sheng C.; Wang W.; Cao Y.; Xu Y.; Ji H.; Dong G.; Miao Z.; Yao J.; Zhang W.; New azoles with potent antifungal activity: design, synthesis and molecular docking. Eur J Med Chem 2009,44(10),4218-4226","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/j.ejmech.2011.02.001","volume":"46","author":"Jiang Y.","year":"2011","unstructured":"Jiang Y.; Cao Y.; Zhang J.; Zou Y.; Chai X.; Hu H.; Zhao Q.; Wu Q.; Zhang D.; Jiang Y.; Sun Q.; Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one. Eur J Med Chem 2011,46(7),3135-3141","journal-title":"Eur J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1016\/j.ejmech.2011.04.022","volume":"46","author":"Chai X.","year":"2011","unstructured":"Chai X.; Zhang J.; Cao Y.; Zou Y.; Wu Q.; Zhang D.; Jiang Y.; Sun Q.; Design, synthesis and molecular docking studies of novel triazole as antifungal agent. Eur J Med Chem 2011,46(7),3167-3176","journal-title":"Eur J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.bmcl.2010.12.006","volume":"21","author":"Chai X.","year":"2011","unstructured":"Chai X.; Zhang J.; Cao Y.; Zou Y.; Wu Q.; Zhang D.; Jiang Y.; Sun Q.; New azoles with antifungal activity: Design, synthesis, and molecular docking. Bioorg Med Chem Lett 2011,21(2),686-689","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.ejmech.2011.02.042","volume":"46","author":"Xu J.","year":"2011","unstructured":"Xu J.; Cao Y.; Zhang J.; Yu S.; Zou Y.; Chai X.; Wu Q.; Zhang D.; Jiang Y.; Sun Q.; Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives. Eur J Med Chem 2011,46(7),3142-3148","journal-title":"Eur J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s12272-013-0063-0","volume":"36","author":"Yu S.","year":"2013","unstructured":"Yu S.; Wang N.; Chai X.; Wang B.; Cui H.; Zhao Q.; Zou Y.; Sun Q.; Meng Q.; Wu Q.; Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment. Arch Pharm Res 2013,36(10),1215-1222","journal-title":"Arch Pharm Res"},{"key":"ref=61","first-page":"1459","volume":"9","author":"Xu K.","year":"2015","unstructured":"Xu K.; Huang L.; Xu Z.; Wang Y.; Bai G.; Wu Q.; Wang X.; Yu S.; Jiang Y.; Design, synthesis, and antifungal activities of novel triazole derivatives containing the benzyl group. Drug Des Devel Ther 2015,9,1459-1467","journal-title":"Drug Des Devel Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejmech.2014.01.009","volume":"74","author":"Zou Y.","year":"2014","unstructured":"Zou Y.; Yu S.; Li R.; Zhao Q.; Li X.; Wu M.; Huang T.; Chai X.; Hu H.; Wu Q.; Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates. Eur J Med Chem 2014,74,366-374","journal-title":"Eur J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"13486","DOI":"10.1039\/c3ra41310a","volume":"3","author":"Yu S.","year":"2013","unstructured":"Yu S.; Wang L.; Wang Y.; Song Y.; Cao Y.; Jiang Y.; Sun Q.; Wu Q.; Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives containing the 1,2,3-triazole group. RSC Advances 2013,3(32),13486-13490","journal-title":"RSC Advances"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1039\/c3md20086h","volume":"4","author":"Yu S.","year":"2013","unstructured":"Yu S.; Chai X.; Wang N.; Cui H.; Zhao Q.; Hu H.; Zou Y.; Sun Q.; Wu Q.; Synthesis and antifungal activity of the novel triazole compounds. MedChemComm 2013,4(4),704-708","journal-title":"MedChemComm"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"11333","DOI":"10.3390\/molecules190811333","volume":"19","author":"Wang Y.","year":"2014","unstructured":"Wang Y.; Xu K.; Bai G.; Huang L.; Wu Q.; Pan W.; Yu S.; Synthesis and antifungal activity of novel triazole compounds containing piperazine moiety. Molecules 2014,19(8),11333-11340","journal-title":"Molecules"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ardp.19853180210","volume":"318","author":"Gatti R.","year":"1985","unstructured":"Gatti R.; Cavrini V.; Roveri P.; Luglio G.; Synthesis and antimycotic activity of some 3-(1-imidazolylmethyl)indoles. Arch Pharm (Weinheim) 1985,318(2),157-160","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1016\/S0040-4039(01)01492-7","volume":"42","author":"Sugiyama H.","year":"2001","unstructured":"Sugiyama H.; Yokokawa F.; Aoyama T.; Shioiri T.; Synthetic studies of N-reverse prenylated indole. An efficient synthesis of antifungal indole alkaloids and N-reverse prenylated tryptophan. Tetrahedron Letters -. Tetrahedron Lett 2001,42,7277-7280","journal-title":"Tetrahedron Lett"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.bmc.2005.11.025","volume":"14","author":"Dandia A.","year":"2006","unstructured":"Dandia A.; Singh R.; Khaturia S.; M\u00e9rienne C.; Morgant G.; Loupy A.; Efficient microwave enhanced regioselective synthesis of a series of benzimidazolyl\/triazolyl spiro [indole-thiazolidinones] as potent antifungal agents and crystal structure of spiro[3H-indole-3,2\u2032-thiazolidine]-3\u2018(1,2,4-triazol-3-yl)-2,4\u2019(1H)-dione. Bioorg Med Chem 2006,14(7),2409-2417","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.bmc.2005.11.054","volume":"14","author":"Tiwari R.K.","year":"2006","unstructured":"Tiwari R.K.; Verma A.K.; Chhillar A.K.; Singh D.; Singh J.; Kasi Sankar V.; Yadav V.; Sharma G.L.; Chandra R.; Synthesis and antifungal activity of substituted-10-methyl-1,2,3,4-tetrahydropyrazino[1,2-a]indoles. Bioorg Med Chem 2006,14(8),2747-2752","journal-title":"Bioorg Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1016\/j.bmcl.2007.04.038","volume":"17","author":"Lebouvier N.","year":"2007","unstructured":"Lebouvier N.; Pagniez F.; Duflos M.; Le Pape P.; Na Y.M.; Le Baut G.; Le Borgne M.; Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety. Bioorg Med Chem Lett 2007,17(13),3686-3689","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=71","first-page":"73","volume":"11","author":"Pagniez F.","year":"2001","unstructured":"Pagniez F.; Le Pape P.; New fluorometric screening test for possible antifungal drugs. J Med Mycol 2001,11,73-78","journal-title":"J Med Mycol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/14756366.2019.1705292","volume":"35","author":"Pagniez F.","year":"2020","unstructured":"Pagniez F.; Lebouvier N.; Na Y.M.; Ourliac-Garnier I.; Picot C.; Le Borgne M.; Le Pape P.; Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent. J Enzyme Inhib Med Chem 2020,35(1),398-403","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.5012\/bkcs.2010.31.11.3467","volume":"31","author":"Na Y.M.","year":"2010","unstructured":"Na Y.M.; Synthesis and activity of novel indole linked triazole derivatives as antifungal agents. Bull Korean Chem Soc 2010,31,3467-3470","journal-title":"Bull Korean Chem Soc"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0223-5234(02)00005-3","volume":"38","author":"Na Y-M.","year":"2003","unstructured":"Na Y-M.; Le Borgne M.; Pagniez F.; Le Baut G.; Le Pape P.; Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives. Eur J Med Chem 2003,38(1),75-87","journal-title":"Eur J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5012\/bkcs.2011.32.1.307","volume":"32","author":"Na Y-M.","year":"2011","unstructured":"Na Y-M.; Synthesis and activity of novel 1-halogenobenzylindole linked triazole derivatives as antifungal agents. Bull Korean Chem Soc 2011,32(1),307-310","journal-title":"Bull Korean Chem Soc"},{"key":"ref=76","first-page":"529","volume":"28","author":"Sorbera L.","year":"2003","unstructured":"Sorbera L.; Bartroli J.; Casta\u00f1er J.; Albaconazole. Drugs of The Future - DRUG FUTURE, 2003,28(6),529-537"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/jm9707277","volume":"41","author":"Bartroli J.","year":"1998","unstructured":"Bartroli J.; Turmo E.; Alguer\u00f3 M.; Boncompte E.; Vericat M.L.; Conte L.; Ramis J.; Merlos M.; Garc\u00eda-Rafanell J.; Forn J.; New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. J Med Chem 1998,41(11),1869-1882","journal-title":"J Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","volume":"20","author":"Kathiravan M.K.","year":"2012","unstructured":"Kathiravan M.K.; Salake A.B.; Chothe A.S.; Dudhe P.B.; Watode R.P.; Mukta M.S.; Gadhwe S.; The biology and chemistry of antifungal agents: a review. Bioorg Med Chem 2012,20(19),5678-5698","journal-title":"Bioorg Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1021\/jm4016284","volume":"57","author":"Cao X.","year":"2014","unstructured":"Cao X.; Sun Z.; Cao Y.; Wang R.; Cai T.; Chu W.; Hu W.; Yang Y.; Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility. J Med Chem 2014,57(9),3687-3706","journal-title":"J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.bmcl.2017.03.062","volume":"27","author":"Xie F.","year":"2017","unstructured":"Xie F.; Ni T.; Zhao J.; Pang L.; Li R.; Cai Z.; Ding Z.; Wang T.; Yu S.; Jin Y.; Zhang D.; Jiang Y.; Design, synthesis, and in vitro evaluation of novel antifungal triazoles. Bioorg Med Chem Lett 2017,27(10),2171-2173","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s12272-012-1105-8","volume":"35","author":"Chai X.","year":"2012","unstructured":"Chai X.; Yu S.; Jiang Y.; Zou Y.; Wu Q.; Zhang D.; Jiang Y.; Cao Y.; Sun Q.; Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent. Arch Pharm Res 2012,35(11),1895-1901","journal-title":"Arch Pharm Res"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.126951","volume":"30","author":"Ding Z.","year":"2020","unstructured":"Ding Z.; Ni T.; Xie F.; Hao Y.; Yu S.; Chai X.; Jin Y.; Wang T.; Jiang Y.; Zhang D.; Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus. Bioorg Med Chem Lett 2020,30(4)","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1021\/acs.jmedchem.7b01138","volume":"61","author":"Thamban Chandrika N.","year":"2018","unstructured":"Thamban Chandrika N.; Shrestha S.K.; Ngo H.X.; Tsodikov O.V.; Howard K.C.; Garneau-Tsodikova S.; Alkylated piperazines and piperazine-azole hybrids as antifungal agents. J Med Chem 2018,61(1),158-173","journal-title":"J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103060","volume":"90","author":"Mahmoudi Y.","year":"2019","unstructured":"Mahmoudi Y.; Badali H.; Hashemi S.M.; Ansari M.; Fakhim H.; Fallah M.; Shokrzadeh M.; Emami S.; New potent antifungal triazole alcohols containing N-benzylpiperazine carbodithioate moiety: Synthesis, in vitro evaluation and in silico study. Bioorg Chem 2019,90","journal-title":"Bioorg Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jscs.2018.10.003","volume":"23","author":"Ni T.","year":"2019","unstructured":"Ni T.; Pang L.; Cai Z.; Xie F.; Ding Z.; Hao Y.; Li R.; Yu S.; Chai X.; Wang T.; Jin Y.; Zhang D.; Jiang Y.; Design, synthesis, and in vitro antifungal evaluation of novel triazole derivatives bearing alkynyl side chains. J Saudi Chem Soc 2019,23(5),576-585","journal-title":"J Saudi Chem Soc"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/jac\/dkz280","volume":"74","author":"Rudramurthy S.M.","year":"2019","unstructured":"Rudramurthy S.M.; Colley T.; Abdolrasouli A.; Ashman J.; Dhaliwal M.; Kaur H.; Armstrong-James D.; Strong P.; Rapeport G.; Schelenz S.; Ito K.; Chakrabarti A.; In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris. J Antimicrob Chemother 2019,74(10),2943-2949","journal-title":"J Antimicrob Chemother"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02280-16","volume":"61","author":"Colley T.","year":"2017","unstructured":"Colley T.; Alanio A.; Kelly S.L.; Sehra G.; Kizawa Y.; Warrilow A.G.S.; Parker J.E.; Kelly D.E.; Kimura G.; Anderson-Dring L.; Nakaoki T.; Sunose M.; Onions S.; Crepin D.; Lagasse F.; Crittall M.; Shannon J.; Cooke M.; Bretagne S.; King-Underwood J.; Murray J.; Ito K.; Strong P.; Rapeport G.; In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection. Antimicrob Agents Chemother 2017,61(5),1-14","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/jac\/dkl182","volume":"58","author":"Banfi E.","year":"2006","unstructured":"Banfi E.; Scialino G.; Zampieri D.; Mamolo M.G.; Vio L.; Ferrone M.; Fermeglia M.; Paneni M.S.; Pricl S.; Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. J Antimicrob Chemother 2006,58(1),76-84","journal-title":"J Antimicrob Chemother"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1016\/j.ejmech.2008.07.012","volume":"44","author":"Rezaei Z.","year":"2009","unstructured":"Rezaei Z.; Khabnadideh S.; Pakshir K.; Hossaini Z.; Amiri F.; Assadpour E.; Design, synthesis, and antifungal activity of triazole and benzotriazole derivatives. Eur J Med Chem 2009,44(7),3064-3067","journal-title":"Eur J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1128\/AAC.46.5.1447-1454.2002","volume":"46","author":"Liu Y.","year":"2002","unstructured":"Liu Y.; Ryan M.E.; Lee H-M.; Simon S.; Tortora G.; Lauzon C.; Leung M.K.; Golub L.M.; A chemically modified tetracycline (CMT-3) is a new antifungal agent. Antimicrob Agents Chemother 2002,46(5),1447-1454","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/157018010789869415","volume":"7","author":"Kokil G.R.","year":"2010","unstructured":"Kokil G.R.; Rewatkar P.V.; Gosain S.; Aggarwal S.; Verma A.; Kalra A.; Thareja S.; Synthesis and in vitro evaluation of novel 1, 2, 4-triazole derivatives as antifungal agents. Lett Drug Des Discov 2010,7(1),46-49","journal-title":"Lett Drug Des Discov"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"S3239","DOI":"10.1016\/j.arabjc.2013.12.021","volume":"10","author":"Hari Narayana Moorthy N.S.","year":"2017","unstructured":"Hari Narayana Moorthy N.S.; Vittal U.B.; Karthikeyan C.; Thangapandian V.; Venkadachallam A.P.; Trivedi P.; Synthesis, antifungal evaluation and in silico study of novel Schiff bases derived from 4-amino-5(3,5-dimethoxy-phenyl)-4H-1,2,4-triazol-3-thiol. Arab J Chem 2017,10,S3239-S3244","journal-title":"Arab J Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.arabjc.2011.01.033","volume":"6","author":"Mange Y.J.","year":"2013","unstructured":"Mange Y.J.; Isloor A.M.; Malladi S.; Isloor S.; Fun H-K.; Synthesis and antimicrobial activities of some novel 1,2,4-triazole derivatives. Arab J Chem 2013,6(2),177-181","journal-title":"Arab J Chem"},{"key":"ref=94","author":"Mackie T.J.","year":"1989","unstructured":"Mackie T.J.; McCartney J.E.; Collee J.G.; Mackie T.J.; Mackie 1989","journal-title":"Mackie"},{"key":"ref=95","first-page":"244","volume":"3","author":"Goyal P.K.","year":"2010","unstructured":"Goyal P.K.; Bhandari A.; Rana A.C.; Jain C.B.; Synthesis of some 3-substituted -4h-1, 2, 4-triazole derivatives with potent anti-inflammatory activity. Asian J Pharma Clin Res 2010,3,244-246","journal-title":"Asian J Pharma Clin Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/10426507.2019.1633321","volume":"194","author":"Wu W-N.","year":"2019","unstructured":"Wu W-N.; Jiang Y-M.; Fei Q.; Du H-T.; Synthesis and fungicidal activity of novel 1,2,4-triazole derivatives containing a pyrimidine moiety. Phosphorus Sulfur Silicon Relat Elem 2019,194(12),1171-1175","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/9387102","volume":"2017","author":"Can N.","year":"2017","unstructured":"Can N.; Acar \u00c7evik U.; Sa\u011fl\u0131k B.; Levent S.; Korkut B.; \u00d6zkay Y.; Kaplanc\u0131kl\u0131 Z.; Koparal A.; Synthesis, molecular docking studies, and antifungal activity evaluation of new benzimidazole-triazoles as potential lanosterol 14 \u03b1 -demethylase inhibitors. J Chem 2017,2017,1-15","journal-title":"J Chem"},{"key":"ref=98","first-page":"702","volume":"9","author":"Ahirwar D.L.S.","year":"2017","unstructured":"Ahirwar D.L.S.; Jha K.; Synthesis and characterization of 1,2,4-triazole- pyridine hybrids as potential antimicrobial agents. Intl J Pharma Clin Res 2017,9(12),702-709","journal-title":"Intl J Pharma Clin Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/jhet.3319","volume":"55","author":"Ahirwar J.","year":"2018","unstructured":"Ahirwar J.; Ahirwar D.; Lanjhiyana S.; Jha A.; Dewangan D.; Badwaik H.; Synthesis, characterization, molecular modeling, and biological evaluation of 1,2,4-triazole-pyridine hybrids as potential antimicrobial agents. J Heterocycl Chem 2018,55(11),2598-2606","journal-title":"J Heterocycl Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jfluchem.2016.02.004","volume":"184","author":"Wang B-L.","year":"2016","unstructured":"Wang B-L.; Zhang L-Y.; Zhan Y-Z.; Zhang Y.; Zhang X.; Wang L-Z.; Li Z-M.; Synthesis and biological activities of novel 1,2,4-triazole thiones and bis(1,2,4-triazole thiones) containing phenylpyrazole and piperazine moieties. J Fluor Chem 2016,184,36-44","journal-title":"J Fluor Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cclet.2017.08.035","volume":"29","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Zhan Y-Z.; Ma Y.; Hua X-W.; Wei W.; Zhang X.; Song H-B.; Li Z-M.; Wang B-L.; Synthesis, crystal structure and 3D-QSAR studies of antifungal (bis-)1,2,4-triazole Mannich bases containing furyl and substituted piperazine moieties. Chin Chem Lett 2018,29(3),441-446","journal-title":"Chin Chem Lett"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ardp.201100001","volume":"344","author":"El Bialy S.A.","year":"2011","unstructured":"El Bialy S.A.; Nagy M.M.; Abdel-Rahman H.M.; Efficient regioselective three-component domino synthesis of 3-(1,2,4-Triazol-5-yl)-1,3-thiazolidin-4-ones as potent antifungal and antituberculosis agents. Arch Pharm (Weinheim) 2011,344(12),821-829","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/molecules21050568","volume":"21","author":"Ahmed S.","year":"2016","unstructured":"Ahmed S.; Zayed M.F.; El-Messery S.M.; Al-Agamy M.H.; Abdel-Rahman H.M.; Design, Synthesis, Antimicrobial Evaluation and Molecular Modeling Study of 1,2,4-Triazole-Based 4-Thiazolidinones. Molecules 2016,21(5),568","journal-title":"Molecules"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/jhet.3714","volume":"56","author":"Yusuf M.","year":"2019","unstructured":"Yusuf M.; Thakur S.; Synthesis, characterization","journal-title":"J Heterocycl Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/00304948.2019.1599791","volume":"51","author":"Ali A.A.","year":"2019","unstructured":"Ali A.A.; Soliman M.A.; Aouad M.R.; Messali M.; Rezki N.; Synthesis, characterization, and antimicrobial screening of novel 1,2,4-triazoles, 1,3,4-thiadiazoles, and 1,3,4-oxadiazoles bearing the indole moiety. Org Prep Proced Int 2019,51(3),270-286","journal-title":"Org Prep Proced Int"},{"key":"ref=106","first-page":"70","author":"Frolova Y.","year":"2020","unstructured":"Frolova Y.; Design, synthesis, antimicrobial and antifungal activities of new 1,2,4-triazole derivatives containing 1h-tetrazole moiety. Ankara Universitesi Eczacilik Fakultesi Dergisi, 2020,70-88"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4328\/JCAM.2323","volume":"6","author":"Rao D.V.","year":"2015","unstructured":"Rao D.V.; Prasad A.; Spoorthy Y.N.; Rao D.; Ravindranath L.K.; Synthesis, characterization and antimicrobial evaluation of substituted 1,2,4-triazole thiones containing pyrazole moiety. J Clin Analyt Med 2015,6,590-595","journal-title":"J Clin Analyt Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3390\/molecules23040822","volume":"23","author":"J\u00f3\u017awiak M.","year":"2018","unstructured":"J\u00f3\u017awiak M.; St\u0119pie\u0144 K.; Wrzosek M.; Olejarz W.; Kubiak-Tomaszewska G.; Filipowska A.; Filipowski W.; Struga M.; Synthesis, structural studies and biological evaluation of connections of thiosemicarbazide, 1,2,4-triazole and 1,3,4-thiadiazole with palmitic acid. Molecules 2018,23(4),822","journal-title":"Molecules"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1021\/acsinfecdis.7b00215","volume":"4","author":"Mohammad H.","year":"2018","unstructured":"Mohammad H.; Elghazawy N.H.; Eldesouky H.E.; Hegazy Y.A.; Younis W.; Avrimova L.; Hazbun T.; Arafa R.K.; Seleem M.N.; Discovery of a novel dibromoquinoline compound exhibiting potent antifungal and antivirulence activity that targets metal ion homeostasis. ACS Infect Dis 2018,4(3),403-414","journal-title":"ACS Infect Dis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13065-017-0347-4","volume":"11","author":"Aouad M.R.","year":"2017","unstructured":"Aouad M.R.; Mayaba M.M.; Naqvi A.; Bardaweel S.K.; Al-Blewi F.F.; Messali M.; Rezki N.; Design, synthesis, in silico and in vitro antimicrobial screenings of novel 1,2,4-triazoles carrying 1,2,3-triazole scaffold with lipophilic side chain tether. Chem Cent J 2017,11(1),117-117","journal-title":"Chem Cent J"},{"key":"ref=111","first-page":"1","author":"Gomha S.","year":"2020","unstructured":"Gomha S.; Edrees M.; Muhammad Z.; Kheder N.; Melha S.; Saad A.; Synthesis, characterization, and antimicrobial evaluation of some new 1,4-dihydropyridines-1,2,4-triazole hybrid compounds 2020,1-13","journal-title":"Synthesis, characterization, and antimicrobial evaluation of some new 1,4-dihydropyridines-1,2,4-triazole hybrid compounds"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5155\/eurjchem.4.2.92-97.615","volume":"4","author":"Behalo M.","year":"2013","unstructured":"Behalo M.; Aly A.; Wasfy A.; Mohamed M.; Synthesis of some novel 1,2,4-triazole derivatives as potential antimicrobial agents. Eur J Chem 2013,4,92-97","journal-title":"Eur J Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.arabjc.2016.06.007","volume":"11","author":"Tratrat C.","year":"2018","unstructured":"Tratrat C.; Haroun M.; Paparisva A.; Geronikaki A.; Kamoutsis C.; \u0106iri\u0107 A.; Glamo\u010dlija J.; Sokovi\u0107 M.; Fotakis C.; Zoumpoulakis P.; Bhunia S.S.; Saxena A.K.; Design, synthesis and biological evaluation of new substituted 5-benzylideno-2-adamantylthiazol[3,2-b][1,2,4]triazol-6(5H)ones. Pharmacophore models for antifungal activity. Arab J Chem 2018,11(4),573-590","journal-title":"Arab J Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/acs.jafc.9b06006","volume":"68","author":"Wang T.","year":"2020","unstructured":"Wang T.; Yang S.; Li H.; Lu A.; Wang Z.; Yao Y.; Wang Q.; Discovery, structural optimization, and mode of action of essramycin alkaloid and its derivatives as anti-tobacco mosaic virus and anti-phytopathogenic fungus agents. J Agric Food Chem 2020,68(2),471-484","journal-title":"J Agric Food Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"11598","DOI":"10.1021\/acs.jafc.9b04733","volume":"67","author":"Fan Z.","year":"2019","unstructured":"Fan Z.; Shi J.; Luo N.; Ding M.; Bao X.; Synthesis, crystal structure, and agricultural antimicrobial evaluation of novel quinazoline thioether derivatives incorporating the 1,2,4-triazolo[4,3-a]pyridine moiety. J Agric Food Chem 2019,67(42),11598-11606","journal-title":"J Agric Food Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1021\/jf9029628","volume":"58","author":"Fan Z.","year":"2010","unstructured":"Fan Z.; Yang Z.; Zhang H.; Mi N.; Wang H.; Cai F.; Zuo X.; Zheng Q.; Song H.; Synthesis, crystal structure, and biological activity of 4-methyl-1,2,3-thiadiazole-containing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. J Agric Food Chem 2010,58(5),2630-2636","journal-title":"J Agric Food Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.1021\/acs.jafc.8b03797","volume":"66","author":"Zhao B.","year":"2018","unstructured":"Zhao B.; Fan S.; Fan Z.; Wang H.; Zhang N.; Guo X.; Yang D.; Wu Q.; Yu B.; Zhou S.; Discovery of Pyruvate Kinase as a Novel Target of New Fungicide Candidate 3-(4-Methyl-1,2,3-thiadiazolyl)-6-trichloromethyl-[1,2,4]-triazolo-[3,4- b][1,3,4]-thiadizole. J Agric Food Chem 2018,66(46),12439-12452","journal-title":"J Agric Food Chem"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183462","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183462\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:10:54Z","timestamp":1696335054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183462\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":117,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,11,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026620666200704140107","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}